• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Chrysalis Collaborates with NIAID on Chrysalin for Radiation Injury

    BUSINESSWIRE

    Chrysalis BioTherapeutics Selected to Present at Respiratory Innovation Summit

    BUSINESSWIRE

    Chrysalis Receives FDA Approval to Initiate Trials with Chrysalin™ (TP508)

    BUSINESSWIRE

    Intouch Group Launches Pro-Bono Alliance with The Chrysalis Initiative

    PRNEWSWIRE

    Chrysalis BioTherapeutics Receives $10.4 Million From BARDA

    BUSINESSWIRE

    Chrysalis Receives $10.4 M From BARDA to Continue Development of TP508

    BUSINESSWIRE

    Chrysalis Receives Additional Funding from the National Institutes of Health

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.